Since late 2022, bad news in biotech has been nearly inescapable: flopped trials, slashed drug pipelines, bankruptcies and ...

The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...

Overall, biotech layoffs claimed at least 10,000 jobs within the sector last year, according to data compiled by BioPharma Dive. Many of those jobs were at smaller biotech companies more ...

In the first quarter of 2023, 56 biopharmas laid off staff—an 87% jump compared to 2022, when 30 companies reported layoffs for the same period, according to a Fierce Biotech analysis. | In the ...

The biotech index fund XBI has climbed nearly 9% so far in 2023 and is up 11.74% over the last six months, trading at $88.80 per share. At its peak on Feb. 5, 2022, the XBI was trading at $166.78.

After some years of a thriving life sciences job market, the Maryland biotech industry has had more than 1,200 layoffs in the last year, according to the State of Maryland’s Work Adjustment and ...

In January, tech and biotech companies orchestrated the layoffs of 5,384 employees in Bay Area cities. In March, the projected layoff numbers currently total about 5,248.

“I think this is the nature of the beast in biotech,” Gillon said of recent ups and downs in the industry, including another round of layoffs at New Haven’s RallyBio that was announced this ...

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs by Charlotte Schubert on December 27, 2022 at 7:53 am Share 8 ...

The biotech sector is off to a rocky start this year. After some signs of growth in late 2022, funding is down in 2023. Jefferies analysts said that if things don't improve, we'll see more layoffs ...

But the stock market paints a different picture of an industry that is a linchpin of the Massachusetts economy. For more than a year, U.S. biotech stocks have been down overall, some by up to 80% ...

The carnage in biotech is not just affecting the sector’s workforce — it’s punching a hole in Greater Boston’s real estate market.